Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK’s NICE Seeks Feedback On Proposed Improvements To Its Processes

Executive Summary

Proposals extend the health technology appraisal body's focus beyond final guidance to support for early development and real world performance.

You may also be interested in...



Last Chance To Influence Changes To NICE Methods & Processes In England

Companies selling gene therapies and other high-cost, long-term treatments may be disappointed but unsurprised to learn that NICE will not immediately introduce any change to discount rates, which are used in health technology appraisals to better understand the long-term costs and benefits.

Regulatory And HTA Alignment Key To Attracting Investors To UK

The COVID-19 pandemic has offered lessons on how collaboration can get important treatments to patients more quickly.

UK: RWD At Center Of NICE Five-Year Strategy

NICE will develop standards for using real world data as part of a new five-year strategic plan that the UK health technology assessment body hopes will make it a leader in the use of research and data.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS143731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel